My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  partner  alliance managers  partners  ecosystem  partnerships  alliance manager  The Rhythm of Business  partnership  Jan Twombly  Vantage Partners  biopharma  Eli Lilly and Company  governance  Strategic Alliance Magazine  IBM  IoT  ASAP BioPharma Conference  cloud  strategy  healthcare  innovation  NetApp  2015 ASAP Global Alliance Summit  Christine Carberry  Cisco 

A Virtual Event, but a Rich, Living Community—Thanks to You!

Posted By Michael J. Burke, Wednesday, July 1, 2020

What a day! And what a Summit!

Thursday, the final day of the 2020 ASAP Global Alliance Summit, was filled with highlights, and served as a resounding demonstration that the ASAP community is alive and well and that the whole organization and its members and staff are supremely flexible and able to pivot from an in-person gathering to a very successful virtual event.

Flexibility and agility, in fact, were two of the recurring themes of this year’s Summit, and its last day was no exception. The day’s livestream programming began with an in-depth panel discussion, “Biopharma Commercial Alliance Management Challenges,” skillfully moderated by Jan Twombly, CSAP, president of The Rhythm of Business, and featuring eminent panelists Brooke Paige, CSAP, former vice president of alliance management at Pear Therapeutics and ASAP board chair; David S. Thompson, CSAP, chief alliance officer at Eli Lilly and Company; and Andrew Yeomans, CSAP, global alliance lead for UCB.

Aligning Around the North Star

Commercial alliances are the go-to-market phase of biopharma partnering, and thus there’s often a lot riding on their success or failure. The panelists discussed various aspects of delivering value from commercial alliances given the business risks, human risks, and legal uncertainties; the prospect of misalignment between partners; the perils of operating in different geographic regions with their varying cultures and regulations; the need for speed and flexibility; and other pitfalls.

Amid such challenges, alliance managers have to keep their eyes on the prize—or, as Paige put it, “It always goes back to the basics: providing alignment by constantly pointing to the North Star of the alliance.”

Twombly noted that bringing partners together to hash out a commercial strategy to maximize value coming from the alliance—and then implementing it effectively—is always “the crux of the matter.”

Yeomans, citing an alliance that operated in China as well as other experiences, said the constantly accelerating speed of events means that even the most experienced alliance managers end up “learning on the job.” “Things are so much more immediate in the real world,” he said. “A lot of things can happen fast.”

More than one panelist mentioned the human element in these alliances—from training alliance professionals to dealing with human risk and misalignment. “It comes down to, do you have the right people?” Paige said. “You have to have the right people with the right mindset” to make the alliance work effectively.

Driving alignment, according to Yeomans, happens in “three buckets”: formal (contract terms), semiformal (governance), and informal, which includes both performing regular health checks and doing the internal work of alignment to “get your own house in order.” In this way issues get turned around and resolved, and escalation is avoided. “This is where alliance management can really come to the fore and add value,” he said.

He also urged alliance managers to work toward achieving a “complementary fit” in the partnership and to “be a conduit” between global and regional representatives and between partners. “Be adaptable and be ahead of the curve. In this way you become almost the go-to person,” he said.

Despite the challenges, Yeomans said he could “wholeheartedly recommend” getting into commercial alliances. “Venture forth. Go forth and conquer!” he exhorted.

Influencers, Referral Partners, Resellers, and Customers

The next presentation in today’s livestream was also concerned with go-to-market partnering, albeit geared more toward the tech industry—but with broader applicability as well. Larry Walsh, CEO and chief analyst of The 2112 Group, spoke on “Making Everyone a Part of the Sales Process”—and by “everyone” he meant not just resellers, but also influencers and referral partners. All have a role to play, and if handled correctly, all contribute to the eventual sale and the booking of revenue.

In fact, the customer should also be included in this continuum, as a satisfied customer could be converted into an influencer, or even a referrer, according to Walsh. He quoted one of his “heroes,” Peter Drucker—no doubt a hero to some others in the ASAP community—who said, “The purpose of a business is to create a customer.”

“That’s why we have channels,” Walsh elaborated. “You try to create points of sale as close to the customer as possible.”

Walsh reminded the audience that the oft-mentioned “customer journey” is in reality just “part of the totality of their experience,” in which even if they’re not buying your brand, they’re still making judgments on it one way or the other. Thus it’s important to try to effectively engage everyone along the continuum from influencers to referrers to resellers to customers because, while expectations should not be overestimated, successful referral programs can be very effective. “Referrals have a lot of power!” Walsh enthused.

Since customers who are happy with a product or solution can become influencers, and influencers can become referrers, and a referral partner may even seem to be a sort of “lightweight reseller” in Walsh’s phrase, this seems to ring true. It also dovetailed with something that Tiffani Bova of Salesforce said on the first day of this year’s Summit: “Your greatest sales force is your customers and partners advocating on your behalf.”

Partner to Partner in the Ecosystem Cloud

“Customers and partners” was a theme of the day’s final presentation as well. Amit Sinha, chief customer officer and cofounder of WorkSpan, and Dan Rippey, director of engineering for Microsoft's One Commercial Partner program, gave a presentation with the lengthy title “How the Microsoft Partner-to-Partner Program Is Disrupting How Technology Companies Are Leveraging the Power of Ecosystems to Grow Their Business, Acquire New Customers, and Gain Competitive Advantage.”

It’s a mouthful, no doubt, but Sinha and Rippey provided some great insights into, first, how WorkSpan uses its Ecosystem Cloud product to help alliance managers, channel partners—really anyone who puts partners together and seeks to manage and keep track of a multipartner ecosystem—both collaborate better and gain greater visibility into the tasks, activities, processes, pipelines, workflows, etc., that are creating value.

Sinha noted that traditionally, “a lot of partnering is meeting people.” Current conditions certainly make that challenging—our Summit being no exception—but he said that with Ecosystem Cloud, remote work becomes more possible and effective and “we can scale even in COVID times.” In addition, as partnerships become more multi-way and complex, these tools become even more necessary. “It’s shifting toward an ecosystem,” he said. “It’s multipartner.”

Among the major partners in this ecosystem is Microsoft, which is where Rippey comes in. As Microsoft has shifted over the years from selling products to selling more solution-based offerings, it has also shifted from an emphasis on individual partnerships—or “pick a partner to work with the customer,” as he said—to more collaborative solution creation and selling arrangements involving multiple partners.

Microsoft realized that it needed to encourage partner-to-partner—or P2P—collaboration in order to push the company forward and grow the ecosystem. It needed to “embrace multiparty conversations,” in Rippey’s words. “In some cases Microsoft just gets out of the way. It really puts the partners at the center of the conversation.” In other cases, Microsoft comes back to the table as needed, but either way, he said, “This puts the partner in the lead.”

When a new solution is discussed, the first question is, “Did somebody already build this?” In that case those partners can be pulled in to tailor the solution to the new end customer in mind. Otherwise, “is this an opportunity,” Rippey said, to design something new?

He noted that while Microsoft doesn’t always have to lead these discussions, they seem to be fruitful in any case, and the P2P program has led to “exponential growth.” Some of its new capabilities will be “lighting up for our partners next year,” he said. “It is Microsoft’s joy to see those partners succeed, [often] without needing our help.”

New Thinking at the New Breakfast Table

This does not come without new thinking, or at times “uncomfortable” negotiations or conversations, Rippey admitted. But he said it forces a large enterprise like Microsoft to be “putting [our] startup hat on again” and to get out and “hustle at all tiers of the ecosystem.” As is often the case in the IT world, some of Microsoft’s competitors are also involved, because “we’re better together.”

And while the P2P platform—just like a social media site—is in need of “moderation,” as Sinha put it, so that there are rules and community norms and some structure, it’s also important to be fairly straightforward about your company’s needs, capabilities, and interests.

“A negotiation is designed to be uncomfortable,” Rippey said. “Be up front, be blunt about what you need, and be OK to say, ‘It looks like we’re misaligned here.’”

Both Sinha and Rippey commented on the need for speed, agility, and flexibility in working with partners, especially in the current pandemic conditions.

“The nature of collaboration has always been getting together to do things,” Sinha said. “Getting together in a room, in each other’s offices, to do joint business planning. Now we have to do more remote collaboration.”

Rippey noted that Microsoft itself had to transition its usual annual “show” from in-person in Las Vegas to virtual this year, which he said was “incredibly hard to do.” But, he added, “It’s not about the show, it’s about the conversations in the hallways. You walk into breakfast and you have nothing, but you sit down next to someone and you walk out of breakfast and you have something—a connection, a business card. It’s really hard to do digitally, and you can’t do it without a platform. We’re providing that new breakfast table.”

Here’s hoping we can all meet again before long over breakfast, lunch, dinner, or a beverage to share insights and stories and to make connections. But until that time, it’s nice to know that we can meet virtually as members of the ASAP community and still get the benefits of sharing all the great wisdom, information, and learning that so many have been able to contribute.

Tags:  aligning  Alliance Management  Amit Sinha  Andrew Yeomans  Biopharma  Brooke Paige  channel  cloud  Commercial  Dan Rippey  David S. Thompson  ecosystem  Eli Lilly and Company  Influencers  Jan Twombly  Larry Walsh  Microsoft  Referral Partners  The 2112 Group  The Rhythm of Business  UCB  WorkSpan 

Share |
PermalinkComments (0)
 

It’s Nearly Here! ASAP’s Virtual Summit About to Start

Posted By Michael J. Burke, Saturday, June 20, 2020

Have you registered yet? I hope so, because it’s almost here. ASAP’s first-ever virtual Global Alliance Summit begins Tuesday, June 23, with livestream sessions running June 23–25 and on-demand sessions available—well, on demand, anytime you want to view them.

As usual, the leading lights in alliance management and partnering will be sharing their insights with the ASAP community, along with some special guests who will provide a look into aspects of the partnering landscape you may be less familiar with.

People like Dr. Louis B. Harrison, MD, FASTRO, of the Moffitt Cancer Center in Tampa, Fla. He’s the chair of the center’s radiation oncology department, but he also happens to be its chief partnership officer, and he’ll be talking about the kinds of partnerships a cancer center engages in and the challenges and opportunities that arise from those engagements. He’ll be leading off day one of the Summit, along with Tiffani Bova, growth and innovation evangelist at Salesforce, whose presentation, “The Untapped Gold Mine of Building Trust, Unconventional Affiliations, and Iteration-Based Partnerships,” looks to be a highlight.

And by the way, aren’t you itching to know the winners of the Alliance Excellence Awards? I know I am, and fortunately the waiting is almost over as these exemplary partnerships will be showcased on the first day as well, with Ard-Pieter de Man, CSAP, PhD, professor at the Vrije Universiteit Amsterdam and coauthor of the recent book How to Survive the Organizational Revolution, handing out the awards.

Day two will see a presentation by Steve Steinhilber, global vice president ecosystem development at Equinix—and an alliance and ecosystem veteran with years of experience at Cisco under his belt—called “Creating Alliances and Digital Ecosystem Capabilities in an Increasingly Platform-Enabled and Interconnected World.” This will be followed by what should be a fascinating panel discussion moderated by Jessica Wadd of Vantage Partners and featuring panelists from across industries, “Managing Power Imbalances: How to Navigate Partnerships Between Large and Small Organizations.” (Does that sound like a perennial topic of interest?) Finally, Wednesday will also boast a talk by Carl DCosta, worldwide general manager of partner success at Blue Yonder, “Foundation for Partner Success in the Digital World.”

Thursday kicks off with another panel, this one moderated by Jan Twombly, president of The Rhythm of Business, dealing with commercial-stage alliances in biopharma and their challenges and featuring nearly a who’s who of pharma alliance leaders: ASAP’s board chair Brooke Paige, formerly vice president of alliance management at Pear Therapeutics; David S. Thompson, chief alliance officer at Eli Lilly and Company; and Andrew Yeomans, global alliance lead at UCB. In addition, Larry Walsh, CEO and chief analyst at The 2112 Group, will speak on how to include everyone in the sales process in today’s interconnected, omni-channel, partnering-everywhere world, while Dan Rippey of Microsoft and Amit Singh of WorkSpan will give an inside look at how Microsoft’s partner-to-partner (P2P) program works to connect the ecosystem and power business growth and competitive advantage.

OK, that’s the three days in a nutshell—but that’s just the livestream content. Did I mention on-demand sessions? The list is extensive, and you’ll want to check a good number of them out. Like these:

  • Session 301: “The Profit Power of Collaboration,” by Robert Porter Lynch, The Warren Company
  • Session 403:  “Resiliency in Alliance Management: How Amgen-UCB Managed the ‘Roller Coaster Ride’ of a Long-standing Alliance,” by Tracy Blois, Amgen; and Alistair Dixon, UCB
  • Session 404: “Integrated Joint Alliance Marketing Best Practices: How to Establish Joint Marketing Moments That Drive Impact,” by Liz Fuller, Citrix
  • Session 501: “How 5G Will Transform and Disrupt Business and Partners,” moderated by Stacy Conrad, TPx, with panelists Manoj Bhatia, Verizon; Pradeep Bhardwaj, Syniverse; and Andreas Westh, Ericsson
  • Session 503:  “Marketplaces: The New Buying Centers in the Age of As-a-Service,” by Glen Kuhne, Ingram Cloud Blue; and Roger Williams, Citrix
  • Session 504:  “The Strategic Partner Executive of the Future and the Skills Needed for Success,” moderated by Norma Watenpaugh, Phoenix Consulting Group, with panelists Rafael Contreras, ServiceNow; Jim Chow, Google Cloud; and Greg Fox, WorkSpan
  • Session 602: “Demystifying the Ecosystem: An Interactive Conversation,” by Claudia Kuzma, Protiviti; and Nancy Ridge, Ridge Innovative
  • Session 702: “Big Pharma M&A and Alliance Portfolios,” moderated by Adam Kornetsky, Vantage Partners, with panelists Mark Coflin and Jeff Hurley, Takeda; Dana Hughes, Pfizer; and Chris Urban, Amgen
  • Session 703: “Absorbing and Facilitating Change: Managing Your Partner Program During Organizational Upheaval,” by Ben Anderson and Susan Cleveland, Thomson Reuters

And while there’s nothing like “being there”—in this case virtually—whether you’re able to participate in the livestream presentations, on-demand sessions, and interactive roundtables that are part of this year’s Summit, you’ll want to check this space during the coming days and weeks, as my colleague Jon Lavietes and I will be blogging both livestream and on-demand sessions to give those who missed it a taste of what’s going on. We hope to whet some appetites for more of this kind of programming, as well as to showcase some of the great content on offer at this year’s virtual Summit.

So tune in, and stay tuned! 

Tags:  Amit Singh  Blue Yonder  Carl DCosta  Dan Rippey  Equinix  Larry Walsh  Louis Harrison  Microsoft  Moffitt Cancer Center  Salesforce  Steve Steinhilber  The 2112 Group  The Rhythm of Business  Tiffani Bova  Vantage Partners  WorkSpan 

Share |
PermalinkComments (0)
 

Making Adjustments: ASAP Global Alliance Summit Now in June!

Posted By Michael Leonetti, CSAP, Monday, March 9, 2020

We’ve all had the experience of an unexpected event that suddenly threw a wrench into our alliances or our lives. Depending on the nature of the event, its magnitude, and how close to home it hits, we generally do our best to understand how the landscape has changed, adjust to the implications, make accommodations, and move forward. Reality may defy our hopes and expectations, but we pick up the pieces, dust ourselves off, and keep getting up in the morning amid the now-altered environment.

So it is with the coronavirus, or COVID-19, whose effects worldwide have already proven serious. Our hearts go out to all those who have been directly affected by this virus, especially the families of those who have died from it around the globe. In addition, this contagious disease—and the fear of it—has already had a significant economic impact, including declines in business and vacation travel and the cancellation or postponement of a number of conventions, conferences, and trade shows in various industries. Most organizations have been forced to respond in some way, whether to shift events to alternative dates or from physical to virtual, to curtail travel to safeguard their people, or to try to limit the damage to their bottom line. Or all of the above.

We at ASAP have faced these challenges as well, resulting in the difficult decision to reschedule our Global Alliance Summit, which had been scheduled for next week, to June 23–25 in Tampa, Florida. In the great scheme of things this move may barely register, but for a member organization like ours, as you can imagine, it’s a big deal. Shifting the Summit to new dates has required a huge and immediate lift on the part of ASAP staff and board, which is ongoing as I write this.

The good news is, the show will go on! I’m very happy that we were able to secure the original conference venue, the Renaissance Tampa International Plaza Hotel, for our late-June dates. I’m even more pleased to report that at present, nearly 75 percent of our presenters, panelists, and moderators have confirmed that they’ll be there.

What this means is that we’ll still have a terrific program, as planned—a program that, as always, includes presentations by some of the alliance and partnering profession’s best and brightest minds and leading lights, including these:

  • A keynote presentation by Steve Steinhilber, global vice president, ecosystems and business development, at Equinix: “Creating Alliances and Digital Ecosystem Capabilities in an Increasingly Platform Enabled and Interconnected World.” Steve ran alliances at Cisco for a number of years, and while there authored the influential book Strategic Alliances: Three Ways to Make Them Work (2008). He was also among those interviewed for our Q1 2020 cover story in Strategic Alliance Quarterly on the rise and far-reaching effects of ecosystems in nearly every industry, and his insights into this important and growing area are sure to be valuable and applicable to any industry.
  • A fascinating panel moderated by Adam Kornetsky of Vantage Partners titled “Big Pharma M&A and Alliance Portfolios: What’s at the End of the Rainbow?” This interactive discussion will feature panelists including Mark Coflin, CSAP, vice president and head of global alliances at Takeda Pharmaceuticals; Dana Hughes, vice president of integration management and alliance management at Pfizer; and Jeffrey C. Hurley, senior director, GBD global alliance lead at Takeda. These longtime ASAP members will share their recent M&A experiences, provide insights into how alliance portfolios have been managed through the transaction process, and engage participants in sharing additional perspectives critical for unlocking and maximizing the full value of an alliance portfolio.
  • A presentation by Dan Rippey, director of engineering for Microsoft’s One Commercial Partner program, and Amit Sinha, chief customer officer and cofounder of WorkSpan, called “How the Microsoft Partner-to-Partner Program Is Disrupting the Way Technology Companies Are Leveraging the Power of Ecosystems for Business Growth, Customer Acquisition, and Gaining a Competitive Advantage.” With the rise of ecosystems has come the increasing deployment of partner-to-partner (P2P) programs, and Microsoft’s may be the largest on the planet, connecting partners directly with each other to deliver value to customers without Microsoft’s intervention. Powered by WorkSpan Ecosystem Cloud, this program increases profitability by selling solutions from one or more of Microsoft’s partners, achieving faster time-to-market by leveraging prebuilt joint solutions, closing larger deals, and reaching more customers by co-selling with other Microsoft partners for a bigger joint pipeline. This new model of partnering has wide applicability and Dan and Amit’s description of how it works is a must-hear.
  • Another terrific panel moderated by Jan Twombly, president of The Rhythm of Business, called “Biopharma Commercial Alliance Management Challenges.” Panelists will include Brooke Paige, CSAP, ASAP board chair and former vice president of alliance management at Pear Therapeutics; and David S. Thompson, CSAP, chief alliance officer at Eli Lilly and Company. In the long life of a successful biopharma alliance, the commercialization phase brings its own particular challenges and problems. This panel promises to be a lively discussion of such topics as how alliance managers deliver value in a commercial alliance, considerations for driving alignment in local geographies and at a corporate level, aspects of alliance governance to get right to maximize value, and much more.

I’m not indulging in hyperbole when I say that these are just a very few of the highlights. Again,  more than three-quarters of the original Summit agenda is planned  to remain intact—including preconference workshops, single-speaker presentations, illuminating panel discussions, and of course, valuable networking opportunities.

We know there are many factors governing decisions on where to travel and why—especially under current conditions. But we’re confident that even after shifting to the June dates, we’ll be fielding a stellar lineup at the Summit in Tampa—one you’ll want to be present for. If you haven’t registered yet and/or for whatever reason were uncertain about attending in March, you now have some extra time to decide.

Additionally, the Renaissance has set up a new block of rooms at our discounted rate of $219.00+ per night. To book your room for the new conference dates, please click on the link below:

https://www.marriott.com/event-reservations/reservation-link.mi?id=1583953400577&key=GRP&app=resvlink

Let’s all try to plan for normal again! Won’t you join us? I hope to see you in Tampa!

Tags:  alliances  Amit Sinha  biopharma  Brooke Paige  Dan Rippey  Dana Hughes  David Thompson  Ecosystems  Eli Lilly and Company  Equinix  Jan Twombly  Jeffrey Hurley  Mark Coflin  Microsoft  P2P  partners  Pfizer  Steve Steinhilber  Takeda  The Rhythm of Business  Vantage Partners  WorkSpan 

Share |
PermalinkComments (0)
 

Collaboration: Easier Said Than Done

Posted By Jan Twombly, CSAP, President, The Rhythm of Business, Thursday, December 12, 2019

The following blog was originally posted by ASAP corporate member and Education Provider Partner,  The Rhythm of Business.

Collaboration is a business buzzword that everyone thinks they know what it means and how to do it, but few truly do; yet it has never been more important than it is today. In addition to the lack of collaborative skills and mindset would-be collaborators also face a Collaboration Paradox— the systems, processes, and policies that have enabled success in the past reinforce barriers impeding success in today’s ecosystem-based collaborative business models. Developing the necessary capability—the mindset, skillset, and toolset for intra- and inter-organizational collaboration—is a work in process for most organizations. This capability also needs a backbone to latch itself to—the culture, policies, and processes of a leadership system that enable and encourage collaborative ways of working.

As a business concept du jour, collaboration means everything from open office concepts to electronic documents that multiple people can work on simultaneously, to team work. These are all elements of collaboration, but they fail to adequately define it. Collaboration is a risk sharing and resource leveraging strategic behavior that necessitates coordinating activities and exchanging information for mutual benefit. It requires an environment of trust, transparency, and respect. It is a comprehensive way of thinking and acting that takes proficiency in multiple skills. It is not a single skill and certainly not a technology.

Companies that are successful in becoming digitally-enabled and customer-obsessed—and therefore prepared to compete as we enter the 2020s—are those best able to collaborate internally and externally. For example, MIT Sloan Management Review’s research finds that: “A focus on collaboration—both within organizations and with external partners and stakeholders—is central to how companies create business value and establish competitive advantage.”[1] According to a study by SAP, “Digital winners tend to have more managers with strong collaboration skills than lower performing companies. In addition, 74 percent of these top performing companies plan to actively nurture the concept of collaboration within their organizations over the next few years.”[2]

Despite collaborative skills becoming ever more the imperative, the reality of collaborative execution is far more challenging than the data would have you believe. In a study from Capgemini, approximately 85 percent of executives believe that their organizations easily collaborate across functions and business units, whereas only a little over 40 percent of their employees—who are actually on the front-lines of collaboration—agree.[3] A Harvard Business Review article on collaboration sheds light on this collaboration gap:

Leaders think about collaboration too narrowly: as a value to cultivate but not a skill to teach. Businesses have tried increasing it through various methods, from open offices to naming it an official corporate goal. While many of these approaches yield progress—mainly by creating opportunities for collaboration or demonstrating institutional support for it—they all try to influence employees through superficial or heavy-handed means, and research has shown that none of them reliably delivers truly robust collaboration.[4]

Does this mean that, while collaboration works in theory, it can’t be practically applied? Not at all. But the question does strike at the heart of the problem—collaboration is easier said than done.

Let’s look at a simple example. A company we were engaged with instituted a campaign to improve collaboration amongst sales teams. The company spent a lot of time, effort, and money on a program intended to promote collaboration within the teams. When the results were evaluated, the program’s sponsors found that level of collaboration hadn’t improved at all.

Our analysis quickly identified why that was the case. The teams’ performance was evaluated by rank-ordering each of the team members from best to worst. And, using the existing performance criteria, the individuals at the top received a number of “rewards” for their success, while the folks at the bottom of the rankings lost their jobs. Clearly, the evaluation process encouraged an “everyman for himself” approach that was exactly the opposite to the desired increase in team collaboration.

That’s the collaboration paradox at work—rewarding the traditional approach while investing to get the desired increase in collaboration. Despite focusing on collaborative skill building, the company neglected to adjust their employee evaluation and reward system—elements of the leadership system—to support collaboration. Leadership worked to change the evaluation system to reward collaboration and our subsequent analysis demonstrated both increases in collaboration and sales performance.

This is but one example of attempts to foster collaboration falling flat because the leadership system was built for competition among team members, not collaboration. Until companies evolve their leadership systems, collaboration as a strategic behavior will remain easier said than done.

[1] David Kiron, “Why Your Company Needs More Collaboration,” MIT Sloan Management Review, Fall 2017

[2] Virginia Backaitis, “Collaboration Leads to Success in Digital Workplaces,” SAP Survey, 2017

[3] “The Digital Culture Challenge: Closing the Employee-Leadership Gap,” Capgemini Digital Transformation Institute, 2018

[4] Francesca Gino, “Cracking the Code on Sustained Collaboration,” Harvard Business Review, November-December 2019.

Tags:  collaboration  collaboration paradox  collaborative skills  Jan Twombly  leadership system  The Rhythm of Business 

Share |
PermalinkComments (0)
 

Where’s the Love? Alliance Managers Show Some…to Medical Affairs

Posted By Michael J. Burke, Wednesday, September 25, 2019

Perhaps one of the less appreciated and less understood roles in biopharma alliances—particularly codevelopment, cocommercial alliances—is that of the medical affairs team, specifically medical science liaisons (MSLs). These field-level folks implement a medical affairs plan and communicate and translate the scientific data from a drug or treatment to health care providers. They own relationships with key opinion leaders (KOLs) and according to surveys are pretty important—the most “clinically useful” people many health care providers deal with.

            “They are translators of the data. They give you the scientific story,” said Mary Jo Struttmann, CA-AM, executive director of alliance management at Astellas. Struttmann participated in a session titled “A Winning Strategy: Show a Little Alliance Management Love for Medical Affairs,” along with Judy Baselice, CA-AM, director of alliance management at Pfizer, and Jan Twombly, CSAP, president of The Rhythm of Business, who moderated the session.

            In addition to being keepers of the scientific narrative, medical affairs people own important relationships with key opinion leaders (KOLs), do professional education, facilitate the creation of publications and presentations at congresses and conferences, get involved in grants and investigator-initiated trials, and at some companies perform other functions as well. They can do what others in a biopharma alliance often can’t: explain the science, interpret the data, describe the mechanism of action of a drug, delve into potential side effects and other questions—all with a primary focus on patient outcomes.

Thus the role of medical affairs is important enough in biopharma that it should be written into the alliance contract, with its own separate budget and work plan, and joint medical affairs committees should be part of that contract and integrated into the governance and work stream teams, according to all three presenters. A number of industry developments, meanwhile, have combined to raise the profile of medical affairs as well, including more payer influence, greater focus on the customer experience, an increased focus on patient outcomes, new medical technologies, and the accelerated pace of scientific discovery.

            Struttmann went so far as to say that in biopharma alliances, there are “three legs of a stool”: commercial, development, and medical affairs. Compliance requirements should keep the scientific areas—including medical affairs—separate from the commercial people, but at the same time there needs to be collaboration and coordination among medical affairs, development, and commercial—a value-added and value-creating role for alliance professionals that ultimately leads to greater value for patients and partners.

            Without adequately acknowledging the role of medical affairs in contracts, there can be significant compliance risk; such agreements may lack definition, enabling either party to overstep boundaries on roles and responsibilities. This includes delineating which activities in the alliance are global and which are territorial or regional, and dividing up who owns each activity accordingly.

In terms of governance, if there is a joint commercial committee, there should also be a joint medical affairs committee, reporting directly to the joint steering committee (JSC). Another best practice is the establishment of a “collaborative leadership team.” This team would be cross-functional and meet perhaps monthly, looking at the alliance as a whole. Representatives from commercial, development, medical affairs, and other areas would be at the table, and in such a model medical affairs can address commercial challenges by acting as a conduit for feedback from health care providers.

By setting up such mechanisms to drive cross-functional work and communication, alliance managers can bring about some positive outcomes in the alliance, including:

  • Creating a single version of “the truth” for ongoing cross-functional work
  • Eliminating the inefficiencies of having one-off conversations or meetings
  • Minimizing the risk of delays due to miscommunication
  • Improving accountability through positive peer pressure

In addition, medical affairs will benefit from these more integrated collaborative structures by:

  • Becoming more aware of commercial challenges
  • Aligning with development on the scientific challenges
  • Acting as a conduit to give insights from health care providers to both development and commercial
  • Facilitating life cycle management planning
  • Creating coordinated engagement plans for KOLs, and…
  • In the end, gaining greater recognition for the importance of medical affairs.

Turnover can be a challenge, as in all alliances, and keeping the medical affairs group separate enough to be elevated and not “washed out” or diluted, as Baselice recommended, but integrated enough to be effective, may be challenging.

But getting this mix of collaboration, division of roles and responsibilities, and coordination right is part of the all-important “last mile of collaborative execution,” as Twombly emphasized. 

Tags:  Alliance Management  Astellas  cross-functional  integrated collaborative structures  Jan Twombly  Judy Baselice  Mary Jo Struttmann  Medical Affairs  Pfizer  The Rhythm of Business 

Share |
PermalinkComments (0)
 
Page 1 of 6
1  |  2  |  3  |  4  |  5  |  6
For more information email us at info@strategic-alliances.org or call +1-781-562-1630